Role of survivin and its splice variants in tumorigenesis
about
Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancerSurvivin: a unique target for tumor therapyLocalization and upregulation of survivin in cancer health disparities: a clinical perspectiveThe anti-apoptosis protein, survivin, mediates gastric epithelial cell cytoprotection against ethanol-induced injury via activation of the p34(cdc2) cyclin-dependent kinaseThe tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidneyP120ctn overexpression enhances beta-catenin-E-cadherin binding and down regulates expression of survivin and cyclin D1 in BEL-7404 hepatoma cellsSurvivin, a molecular target for therapeutic interventions in squamous cell carcinoma.Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo.Characterization of the 12C4 survivin monoclonal antibody and insight into the expression of survivin in human adult tissues.Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.Forced expression of survivin-2B abrogates mitotic cells and induces mitochondria-dependent apoptosis by blockade of tubulin polymerization and modulation of Bcl-2, Bax, and survivin.Generation of a novel transgenic mouse model for bioluminescent monitoring of survivin gene activity in vivo at various pathophysiological processes: survivin expression overlaps with stem cell markersAction of YM155 on clear cell renal cell carcinoma does not depend on survivin expression levelsAberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia.Odontogenic epithelium: immunolabeling of Ki-67, EGFR and survivin in pericoronal follicles, dentigerous cysts and keratocystic odontogenic tumors.MicroRNA regulation and therapeutic targeting of survivin in cancer.Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancerSurvivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST).The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas.Role of the Survivin gene in pathophysiologyMultifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian CancerDownregulation of survivin inhibits proliferation and migration of human gastric carcinoma cellsEvaluation of survivin splice variants in pituitary tumors.The role of survivin in diagnosis, prognosis and treatment of breast cancer.Molecular mechanism of upregulation of survivin transcription by the AT-rich DNA-binding ligand, Hoechst33342: evidence for survivin involvement in drug resistance.Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter.Alternative splicing and its impact as a cancer diagnostic marker.Survivin expression in patients with newly diagnosed nodal diffuse large B cell lymphoma (DLBCL)Survivin study: an update of "what is the next wave"?Relation between expression pattern of p53 and survivin in cutaneous basal cell carcinomas.Developing Michigan Cancer Foundation 7 Cells with Stable Expression of E7 Gene of Human Papillomavirus Type 16.Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death.Transcriptional and post-transcriptional controls of survivin in cancer cells: novel approaches for cancer treatment.Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population.Chk2 phosphorylation of survivin-DeltaEx3 contributes to a DNA damage-sensing checkpoint in cancer.Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients.Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-AnalysisEnhancing effectiveness of the MDR-sensitive compound T138067 using advanced treatment with negative modulators of the drug-resistant protein survivin.Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma.New NSAID targets and derivatives for colorectal cancer chemoprevention.
P2860
Q24306191-B8021A6C-C7DC-45BA-A9E4-7C7CEC3241C1Q26747332-888EA225-ADE4-472B-901D-DA9B60EBAD91Q26799719-79C0A149-81FD-4656-8F8F-3148B1B4A503Q28574978-9C7A8785-EDD7-4C8B-9E79-443218519635Q28581878-40FAC01D-9320-4AFE-97BE-51BB42AE63D7Q33236348-8E150052-2AA3-4207-8798-B64072215AB0Q33634679-C0F3F765-A74F-4A87-9E6D-FF3596EDDF1FQ33652494-F53DE751-29F0-4AB4-BD09-A587F4B9D5C9Q33677012-86648B05-20C2-4B75-A7FD-DF4D1E69652CQ33681985-6EA64419-B777-497F-8026-01C00C16ABFEQ33682487-3B349D48-984F-4B71-AE96-2514A07EDAB7Q33745108-12032BD4-1333-445F-9349-073EC2502C69Q33764288-557019B4-FF4F-4F47-B6D7-B73F260974F0Q34047994-87EBB838-FA13-4545-B1BE-8588B6C28417Q34567778-900C2F32-E5E3-4649-A14C-4695118B02CDQ34991312-B1C39971-5336-49B1-AB5D-5CAC3A4E85E1Q35024933-62352047-4971-4B91-86E5-A332C9E495ADQ35058504-C54619EF-5EBB-46F6-A0CE-613ED81C1563Q35079079-7E8E9F1A-1BE5-4786-847E-FB306A4289BEQ35221844-6EB8735B-2657-44E9-BBD7-38819E3501C3Q35374920-A5989B01-0108-4EE8-A0F0-B75BF01474F0Q35406262-E0778C62-55F5-49BA-8671-825198DC04D1Q35582889-D5AA9EF6-963F-4FBB-A654-71AE50EC6B1DQ35667653-BCCAE6A9-68AB-47F9-98CB-229EE68FA1D6Q35804739-B894224B-E9E5-4B80-BC4A-D08E2B8EB5A0Q36073279-16DADC08-AFBC-4CEF-AD5E-59B3475B5483Q36345822-FE389196-32E0-47EF-97B4-7D2034277292Q36420849-54B0CBF1-DC38-46B5-B30C-D2F2E5193D60Q36430244-3CBAE334-508C-4509-B3AA-450823938CC3Q36473904-8CAD9622-DBA5-4EE9-8C10-E7590F1862C2Q36567611-A797D5EB-EEC0-47FC-8561-FA9418B5B90FQ36609488-80B68CAA-469A-43B5-8FDD-CD4F209F23A7Q36682871-85164AD9-969B-400A-B29A-79E90F0DD647Q36836496-09584C8C-7279-4E71-80F4-51A0B0EA1DA6Q36963631-F8447CFF-7A4E-42FE-A783-D50BF14CB187Q37064709-5660B61E-74E4-479D-B2FD-1D261219407BQ37093298-2D7895B1-F807-49BD-A353-667CDFC6B527Q37427435-23A97256-64FF-43D9-BB2B-8162ED876C67Q37461802-80E5DA06-B003-4743-B414-E2BC868AEB0BQ38034670-6F1C8821-0FBF-444F-9096-3D84028832C1
P2860
Role of survivin and its splice variants in tumorigenesis
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Role of survivin and its splice variants in tumorigenesis
@ast
Role of survivin and its splice variants in tumorigenesis
@en
type
label
Role of survivin and its splice variants in tumorigenesis
@ast
Role of survivin and its splice variants in tumorigenesis
@en
prefLabel
Role of survivin and its splice variants in tumorigenesis
@ast
Role of survivin and its splice variants in tumorigenesis
@en
P2860
P921
P356
P1476
Role of survivin and its splice variants in tumorigenesis
@en
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602340
P407
P577
2005-01-01T00:00:00Z
2005-01-31T00:00:00Z